Stockhub

Easywell Biomedicals, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

26 August 2022

  • curprev 06:4306:43, 26 August 2022 >Nick 1,193 bytes +1,193 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Easywell Biomedicals, Inc., a biopharmaceutical and medical device company, develops and commercializes medical devices, drug substances, and pharmaceutical dosage forms in Taiwan and internationally. The company is developing TLX-001, an anti-cough medicine; TLX-005, an anti-urinary incontinence medicine; TLX-006 for treatment of breast cancer in PMS women; TLX-007 and TLX-004, an anti-depressant; TLX-008 for prevention of..."
Retrieved from "https://stockhub.co/research/Easywell_Biomedicals,_Inc."